Concepedia

Lisa Brunton

LB

Statistics

Publications

23

Citations

1.4K

H-Index

19

Active since

1995

Affiliations

University of Manchester(Current)

Institute of Cancer Research

The Christie NHS Foundation Trust

Cancer Research UK

Hong Kong Polytechnic University

Lisa Brunton is an author at University of Manchester specializing in oncology, medicine, and pharmacology.

ORCID

Publications per year

1995–2022

23

Publications

23

Developing longitudinal qualitative designs: lessons learned and recommendations for health services research

Lynn Calman, Lisa Brunton, Alex Molassiotis · BMC Medical Research Methodology · 2013 · 366 citations · Full text

, , +10

<i>In vitro</i> and <i>In vivo</i> Pharmacokinetic-Pharmacodynamic Relationships for the Trisubstituted Aminopurine Cyclin-Dependent Kinase Inhibitors Olomoucine, Bohemine and CYC202

Florence I. Raynaud, Steven R. Whittaker, Peter M. Fischer et al. · Clinical Cancer Research · 2005 · 131 citations · Full text

, , +17

Preclinical pharmacokinetics and metabolism of a novel prototype DNA-PK inhibitor NU7026

Bernard Nutley, Nicola F. Smith, Angela Hayes et al. · British Journal of Cancer · 2005 · 97 citations · Full text

, , +17

Cellular pharmacology and in vivo activity of a new anticancer agent, ZD9331: a water-soluble, nonpolyglutamatable, quinazoline-based inhibitor of thymidylate synthase.

Ann L. Jackman, Rosemary Kimbell, G. Wynne Aherne et al. · PubMed · 1997 · 92 citations

, , +13

Symptom experience in patients with primary brain tumours: A longitudinal exploratory study

Alex Molassiotis, Barbara A. Wilson, Lisa Brunton et al. · European Journal of Oncology Nursing · 2010 · 81 citations

, , +15

1–5 of 23